Founders' Award Winner - Bone Morphogenetic Protein-2 vs Platelet-Derived Growth Factor for the Treatment of Non-Unions
Bibliographic record
Abstract
In this presentation, Dr. Matthew Raleigh, an orthopedic surgery resident at the University of Toronto, discusses his research on the use of bone morphogenic protein-2 (BMP-2) and platelet-derived growth factor (PDGF) for treating non-unions, particularly focusing on a study supervised by Dr. Aaron Nauth at the Muscle Skeletal Research Laboratory at Saint Michael's Hospital. Raleigh begins by explaining the challenges of treating non-unions, which are incomplete bone healing incidents encountered by many clinicians. He notes that the gold standard for treating non-unions is autologous bone grafting, which has limitations including limited graft volume, surgical site morbidity, and variable rates of union. Thus, there is a need for alternative treatments, such as the promising use of osteoinductive proteins like BMP-2 and PDGF. The study involved creating an atrophic non-union model in 50 Fischer 344 rats, with a critical-sized bone defect stabilized for evaluation. The animals were divided into five groups to compare the effectiveness of PDGF and BMP-2 against a control group. After 10 weeks of healing monitored through bi-weekly radiographs, the effectiveness of the treatments was assessed both qualitatively and quantitatively by two blinded orthopedic surgeons. Results revealed that the BMP-2 treatment group achieved a 100% radiographic union rate, significantly surpassing the 20% in the PDGF group. Additionally, BMP-2 demonstrated superior scores in microCT analysis, indicating greater bone volume and higher mechanical properties compared to PDGF. Though these promising outcomes were based on a small animal model, Raleigh emphasizes the need for future clinical investigations to validate these findings in humans.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.002 | 0.001 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.001 | 0.001 |
| Bibliometrics | 0.001 | 0.000 |
| Science and technology studies | 0.001 | 0.001 |
| Scholarly communication | 0.002 | 0.001 |
| Open science | 0.001 | 0.001 |
| Research integrity | 0.003 | 0.002 |
| Insufficient payload (model declined to judge) | 0.010 | 0.003 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".